Most adults who have taken GLP-1 drugs say they took them to treat a chronic condition including diabetes or heart disease (62%), while about four in ten say they took them primarily to lose weight
Walker RW, Clemente JC, Peter I, Loos RJF
Read on for the latest research on how Omadas Enhanced GLP-1 Care Track can drive favorable health outcomes and decrease financial waste
Importantly, we found that addition of FXR-antagonistic BAs, including TMCA, HDCA or UDCA, could antagonize the effect of CDCA, a potent FXR agonist, on the mRNA expression of Shp and GLP-1 secretion in NCI-H716 cells (Fig
Mice were housed in an animal laboratory room in wire mesh cages under strict hygienic measures and had free access to a standard animal diet and water ad libitum